Vivos Therapeutics
VVOS
VVOS
37 hedge funds and large institutions have $9.14M invested in Vivos Therapeutics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.01% less ownership
Funds ownership: 0.41% → 0.4% (-0.01%)
16% less capital invested
Capital invested by funds: $10.9M → $9.14M (-$1.8M)
Holders
37
Holding in Top 10
–
Calls
$707K
Puts
$568K
Top Buyers
| 1 | +$943K | |
| 2 | +$636K | |
| 3 | +$564K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$320K |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
+$239K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$1.11M | |
| 3 | -$1.06M | |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$465K |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$320K |